[ad_1] Shares of Sangamo Therapeutics Inc. fell 23% in very active trading on Wednesday morning after the company released the first results of a gene-editing trial for a rare metabolic disorder called …
Read More »[ad_1] Researchers at the University of Illinois at Chicago are the first to describe why the CRISPR gene editing sometimes fails to work, and how the process can be made much more …
Read More »[ad_1] Scientists have used the CRISPR-Cas9 gene edition to alleviate some autism symptoms in mice with some form of fragile X syndrome, the most common cause of autism spectrum disorder. Using gold …
Read More »